Palevsky P M
University of Pittsburgh School of Medicine, and Renal Section, Veterans Affairs Pittsburgh Healthcare System, PA 15240, USA.
Semin Nephrol. 1998 Jan;18(1):20-30.
Renal water conservation minimizes the progression of hypernatremia, but the ultimate defense against progressive hypernatremia is the stimulation of thirst by hypertonicity with a resultant increase in water ingestion. Defects in thirst may result from focal lesions involving the hypothalamic osmoreceptors, but more commonly are the result of lesions that impair higher cortical processes required for thirst perception and water ingestion. In response to hypernatremia, the brain undergoes adaptive responses to minimize osmotic shrinkage. Initially there is a rapid uptake of electrolytes, while a slower adaptive phase involves the accumulation of organic osmolytes. The rate at which these solutes can be extruded from the brain dictates the rate at which water replacement can be safely administered during treatment. The incidence of hypernatremia ranges from less than 1% to more than 3% in clinical series. While hypernatremia in nonhospitalized patients is predominantly a disease of the elderly, and is commonly a manifestation of infection or inadequate nursing care, hospital-acquired hypernatremia occurs in a patient population more closely resembling the general hospitalized population and results from inadequate water prescription to patients who are unable to self-regulate water intake. Mortality rates range from approximately 40% to more than than 60%.
肾脏对水的重吸收可使高钠血症的进展降至最低,但对抗高钠血症进展的最终防御机制是高渗状态刺激口渴感,从而导致水摄入量增加。口渴功能缺陷可能源于涉及下丘脑渗透压感受器的局灶性病变,但更常见的是由于损害口渴感知和水摄入所需的高级皮质功能的病变所致。针对高钠血症,大脑会产生适应性反应以尽量减少渗透性萎缩。最初是电解质的快速摄取,而较慢的适应阶段则涉及有机渗透溶质的积累。这些溶质从大脑中排出的速度决定了治疗期间安全补充水分的速度。在临床系列研究中,高钠血症的发生率从不到1%到超过3%不等。非住院患者的高钠血症主要是老年人的疾病,通常是感染或护理不当的表现,而医院获得性高钠血症发生在更类似于一般住院患者群体的患者中,是由于对无法自行调节水摄入量的患者水处方不足所致。死亡率约为40%至超过60%。